Genetic modification of T lymphocytes for adoptive immunotherapy (Q35826514)

10 August 2017

1 reference

title

Genetic modification of T lymphocytes for adoptive immunotherapy (English)

1 reference

10 August 2017

1 reference

2

Malcolm K Brenner

1 reference

10 August 2017

Claudia Rossig

1

1 reference

10 August 2017

publication date

1 July 2004

1 reference

10 August 2017

1 reference

10 August 2017

volume

10

1 reference

10 August 2017

issue

1

1 reference

10 August 2017

page(s)

5-18

1 reference

Adoptive immunotherapy with tumor-infiltrating lymphocytes and interleukin-2 in patients with metastatic malignant melanoma and renal cell carcinoma: a pilot study

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

High-efficiency retroviral-mediated gene transfer into human and nonhuman primate peripheral blood lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

Effects of retroviral vector design on expression of human adenosine deaminase in murine bone marrow transplant recipients engrafted with genetically modified cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

Functional impairment of human T-lymphocytes following PHA-induced expansion and retroviral transduction: implications for gene therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

Administration of herpes simplex-thymidine kinase-expressing donor T cells with a T-cell-depleted allogeneic marrow graft

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

Retrovirus-mediated gene transfer in primary T lymphocytes impairs their anti-Epstein-Barr virus potential through both culture-dependent and selection process-dependent mechanisms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

Retrovirus-mediated gene transfer in primary T lymphocytes: influence of the transduction/selection process and of ex vivo expansion on the T cell receptor beta chain hypervariable region repertoire

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

CD28 costimulation and immunoaffinity-based selection efficiently generate primary gene-modified T cells for adoptive immunotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

Large-scale production of CD4+ T cells from HIV-1-infected donors after CD3/CD28 costimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

Ex vivo expansion of polyclonal and antigen-specific cytotoxic T lymphocytes by artificial APCs expressing ligands for the T-cell receptor, CD28 and 4-1BB.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

Lack of expression from a retroviral vector after transduction of murine hematopoietic stem cells is associated with methylation in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

The cHS4 insulator increases the probability of retroviral expression at random chromosomal integration sites.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

Efficient gene transfer into primary human CD8+ T lymphocytes by MuLV-10A1 retrovirus pseudotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

Reconstitution of Cellular Immunity against Cytomegalovirus in Recipients of Allogeneic Bone Marrow by Transfer of T-Cell Clones from the Donor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

Graft-versus-leukemia reactions in allogeneic chimeras

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

Tolerance to p53 by A2.1-restricted cytotoxic T lymphocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

Gene transfer into humans--immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

Transfer of specificity by murine alpha and beta T-cell receptor genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

Circumventing tolerance to a human MDM2-derived tumor antigen by TCR gene transfer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

Transfer of specificity for human immunodeficiency virus type 1 into primary human T lymphocytes by introduction of T-cell receptor genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

Retroviral transduction of a T cell receptor specific for an Epstein-Barr virus-encoded peptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

Immunotherapy through TCR gene transfer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

The cytoplasmic domain of the T cell receptor zeta chain is sufficient to couple to receptor-associated signal transduction pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

Activation of T cells by a tyrosine kinase activation domain in the cytoplasmic tail of CD3 epsilon.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

Cellular immunity to HIV activated by CD4 fused to T cell or Fc receptor polypeptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the gamma or zeta subunits of the immunoglobulin and T-cell receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

Dual-specific T cells combine proliferation and antitumor activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

Ligand-mediated cytolysis of tumor cells: use of heregulin-zeta chimeras to redirect cytotoxic T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

Antitumor activity of cytotoxic T lymphocytes engineered to target vascular endothelial growth factor receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

Regulation of T-cell antigen receptor (TCR) alpha-chain expression by TCR beta-chain transcripts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

Grafting primary human T lymphocytes with cancer-specific chimeric single chain and two chain TCR.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

Targeting autoantigen-specific T cells and suppression of autoimmune encephalomyelitis with receptor-modified T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

Engineering mouse T lymphocytes specific to type II collagen by transduction with a chimeric receptor consisting of a single chain Fv and TCR zeta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

Characterization of T cell-expressed chimeric receptors with antibody-type specificity for the CD4 binding site of HIV-1 gp120.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

Systemic T cell-independent tumor immunity after transplantation of universal receptor-modified bone marrow into SCID mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

Coupling CD28 co-stimulation to immunoglobulin T-cell receptor molecules: the dynamics of T-cell proliferation and death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

Reshaping human antibodies: grafting an antilysozyme activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

Anti-melanoma antibodies from melanoma patients immunized with genetically modified autologous tumor cells: selection of specific antibodies from single-chain Fv fusion phage libraries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

Therapeutic vaccination against chronic viral infection: the importance of cooperation between CD4+ and CD8+ T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

CD4+ T cells engrafted with a recombinant immunoreceptor efficiently lyse target cells in a MHC antigen- and Fas-independent fashion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

Anti-Tumor CC49-zeta CD4 T cells possess both cytolytic and helper functions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

A phase II randomized study of HIV-specific T-cell gene therapy in subjects with undetectable plasma viremia on combination antiretroviral therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

Signals through T cell receptor-zeta chain alone are insufficient to prime resting T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

The immunological synapse: a molecular machine controlling T cell activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

A Theory of Self-Nonself Discrimination: Paralysis and induction involve the recognition of one and two determinants on an antigen, respectively

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

CD28/B7 system of T cell costimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

Costimulation by CD48 and B7-1 induces immunity against poorly immunogenic tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

Antigen-specific targeting of CD28-mediated T cell co-stimulation using chimeric single-chain antibody variable fragment-CD28 receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

Antigen-dependent CD28 signaling selectively enhances survival and proliferation in genetically modified activated human primary T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

Integrated src kinase and costimulatory activity enhances signal transduction through single-chain chimeric receptors in T lymphocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

Tumor-specific T cell activation by recombinant immunoreceptors: CD3 zeta signaling and CD28 costimulation are simultaneously required for efficient IL-2 secretion and can be integrated into one combined CD28/CD3 zeta signaling receptor molecule

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCRζ /CD28 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

Single-chain antigen recognition receptors that costimulate potent rejection of established experimental tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

Activation of resting human primary T cells with chimeric receptors: costimulation from CD28, inducible costimulator, CD134, and CD137 in series with signals from the TCR zeta chain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

Identification of a murine CD28 dileucine motif that suppresses single-chain chimeric T-cell receptor expression and function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

Direct T cell activation by chimeric single chain Fv-Syk promotes Syk-Cbl association and Cbl phosphorylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

Role of cytotoxic T lymphocytes in Epstein-Barr virus-associated diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

Epstein-Barr virus-specific human T lymphocytes expressing antitumor chimeric T-cell receptors: potential for improved immunotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

Induction of apoptosis in experimental human B cell lymphomas by conditional TRAIL-expressing T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

Combined chemokine and cytokine gene transfer enhances antitumor immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

Autocrine growth and tumorigenicity of interleukin 2-dependent helper T cells transfected with IL-2 gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

A strategy for treatment of Epstein-Barr virus-positive Hodgkin's disease by targeting interleukin 12 to the tumor environment using tumor antigen-specific T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

Anchoring cytokines to tumor cells for the preparation of anticancer vaccines without gene transfection in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

Transforming growth factor-beta in T-cell biology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

Immune-mediated eradication of tumors through the blockade of transforming growth factor-beta signaling in T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

Adapting a transforming growth factor beta-related tumor protection strategy to enhance antitumor immunity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

Antigen-specific therapy for autoimmune disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

Local delivery of interleukin 4 by retrovirus-transduced T lymphocytes ameliorates experimental autoimmune encephalomyelitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

Adoptive immunotherapy of experimental autoimmune encephalomyelitis via T cell delivery of the IL-12 p40 subunit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

Antigen-specific T cell-mediated gene therapy in collagen-induced arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

In vivo migration and function of transferred HIV-1-specific cytotoxic T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

Phenotypic analysis of antigen-specific T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

Bioluminescence imaging of lymphocyte trafficking in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

Serial in vivo imaging of the targeted migration of human HSV-TK-transduced antigen-specific lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

Imaging TCR-dependent NFAT-mediated T-cell activation with positron emission tomography in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

Murine leukemia induced by retroviral gene marking

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

AAV serotype 2 vectors preferentially integrate into active genes in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

Herpes simplex virus thymidine kinase gene transfer for controlled graft-versus-host disease and graft-versus-leukemia: clinical follow-up and improved new vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

Elimination of the truncated message from the herpes simplex virus thymidine kinase suicide gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

A novel 'sort-suicide' fusion gene vector for T cell manipulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

Genetic modification of human T cells with CD20: a strategy to purify and lyse transduced cells with anti-CD20 antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

Folylpolyglutamyl synthetase gene transfer and glioma antifolate sensitivity in culture and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

In vivo human carboxylesterase cDNA gene transfer to activate the prodrug CPT-11 for local treatment of solid tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

A Fas-based suicide switch in human T cells for the treatment of graft-versus-host disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

Expansion and characterization of T cells transduced with a chimeric receptor against ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

A T cell-independent antitumor response in mice with bone marrow cells retrovirally transduced with an antibody/Fc-γ chain chimeric receptor gene recognizing a human ovarian cancer antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

Expression in cytotoxic T lymphocytes of a single-chain anti-carcinoembryonic antigen antibody. Redirected Fas ligand-mediated lysis of colon carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

A chimeric receptor that selectively targets membrane-bound carcinoembryonic antigen (mCEA) in the presence of soluble CEA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

Recognition of human colon cancer by T cells transduced with a chimeric receptor gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

Anti-tumor activity of human T cells expressing the CC49-zeta chimeric immune receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

Chimeric scFv/gamma receptor-mediated T-cell lysis of tumor cells is coregulated by adhesion and accessory molecules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

Functional balance between T cell chimeric receptor density and tumor associated antigen density: CTL mediated cytolysis and lymphokine production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

Targeting of T lymphocytes to melanoma cells through chimeric anti-GD3 immunoglobulin T-cell receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

Targeting of G(D2)-positive tumor cells by human T lymphocytes engineered to express chimeric T-cell receptor genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

Generation of gene-modified T cells reactive against the angiogenic kinase insert domain-containing receptor (KDR) found on tumor vasculature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

Specific targeting of EGP-2+ tumor cells by primary lymphocytes modified with chimeric T cell receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

Comparison of the TCR zeta-chain with the FcR gamma-chain in chimeric TCR constructs for T cell activation and apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

T-cell clones can be rendered specific for CD19: toward the selective augmentation of the graft-versus-B-lineage leukemia effect

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

Characterization of a chimeric T-cell receptor with specificity for the Hodgkin's lymphoma-associated CD30 antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.014

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YMTHE.2004.04.014

1 reference

release_ghihxdhszbactgnkzhwx5nfe5e

10 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ghihxdhszbactgnkzhwx5nfe5e

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference